The PSA Total Test measures the level of prostate-specific antigen in the blood, helping to screen for prostate cancer, monitor existing conditions, and evaluate treatment effectiveness.

Avoid vigorous activities and sexual activity for 48 hours before the test. Inform your doctor about any medications you are taking. No fasting is required.

Elevated PSA levels may suggest prostate inflammation, benign prostatic hyperplasia (BPH), or prostate cancer. Further tests may be required for a definitive diagnosis.

Results are typically available within 24 to 48 hours after the blood sample is collected.

Discuss the results with your healthcare provider to determine the next steps, which may include additional tests or a referral to a specialist for further evaluation.

Candidates include women diagnosed with cervical, endometrial, ovarian, or uterine cancers, or those with precancerous conditions.

G6PD deficiency is a genetic disorder that affects the red blood cells, making them more vulnerable to breaking down prematurely.

Symptoms such as fatigue, jaundice, dark urine, or a family history of G6PD deficiency may indicate the need for this test.

The G6PD test is a simple blood test with minimal risks, similar to any standard blood draw.

Management includes avoiding triggers such as certain medications, foods, and infections that can cause hemolysis.

Early detection in newborns can prevent severe jaundice and related complications by guiding appropriate care and dietary adjustments.